Remdesivir and Favipiravir to be available in two days says Maharashtra Health Minister

Rajesh Tope has assured the availability of the antiviral drugs throughout the state within the next two days.

Remdesivir and Favipiravir to be available in two days says Maharashtra Health Minister

Public hospitals in Maharashtra were reportedly facing a shortage of the experimental drugs Remdesivir and Favipiravir since there was a delay in placing orders by the local authorities. The drug by US-based Gilead Sciences has been approved for sale in India only ten days ago.

Private hospitals and other states like Tamil Nadu, Assam and Karnataka have placed advanced orders for the drugs in bulk. While Maharashtra was among the states that pushed for Remdesivir’s approval, tenders for the drug were said to have not been processed.

Hyderabad-based Hetero Labs, which is the only company approved to sell the drug so far has supplied 20,000 doses, of which more than half went to Tamil Nadu, followed by private hospitals which took 7,000 doses, and the rest to other state hospitals.

Given that Maharashtra was unable to procure the medicine, there was a sense of panic around. However, Maharashtra health minister Rajesh Tope has assured people that within the next two days, the antiviral drugs will be available in all districts of the state. “We are ensuring that it is not available for rich and influential people only,” he said.

Maharashtra is currently the worst-hit state with a total of over 79,000 active cases with the death toll of over 8,000. Over 93,000 patients have reportedly recovered from the contagious virus. 

Tope highlighted that plasma therapy is an effective way of treatment for the virus. He stated that nine out of 10 patients show improvement after the therapy. Furthermore, Tope reiterated that there is no community spread in Maharashtra despite the high number of cases.